AstraZeneca COVID-19 vaccine to be reviewed by WHO, EU regulator
The European Medicines Agency will issue a decision on Thursday
Company
AstraZeneca PLC
LON:AZN
AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease. AstraZeneca has over 67,000 empolyees and operates in over 100 countries with growing presence in important emerging markets.
1084 stories · page 24 of 55
AstraZeneca extends US agreement for COVID-19 treatment candidate
The total value of the contracts with US governments concerning the AZD7442 candidate is US$726mln
Archive
FTSE 100 closes firmly ahead as traders await Central bank comment; Astrazeneca shares rise
The European Medicines Agency has said it has not found any evidence of causality; correlation is not causation, as the old adage has it.
AstraZeneca defends Coronavirus vaccine after new suspensions in Netherlands, Republic of Ireland
Several EU countries and Thailand have put the jab rollout on hold over concerns of blood clots reports in Norway
AstraZeneca vaccine suspended in Denmark over side effect concerns
On Monday, Austria suspended vaccinations after a 49-year old nurse died from severe blood clots.
AstraZeneca says US court rules in its favour for Symbicort litigation
The pharma giant has been in litigation against Mylan and Kindeva
AstraZeneca reportedly cashes in US$1.2bn after selling Moderna, Inc. stake
Shares in Moderna have rocketed over 400% since a year ago after it successfully developed a COVID-19 jab
AstraZeneca withdraws bladder cancer drug in US
The withdrawal is in line with guidance on accelerated approvals that did not meet post-marketing requirements
Coronavirus: AstraZeneca to prepare jabs against new variants by autumn
The firm is testing modified versions of the current vaccine with clinical trials earmarked for the spring
AstraZeneca expects low teens percentage full-year revenue growth excluding COVID-19 vaccine
Sales have been rising thanks to new medicines, with plans to further invest in research and development
Archive
FTSE 100 closes slightly ahead as Brexit and virus fears weigh on sentiment
Britain's blue-chip benchmark finished the day up around four points at 6,528
AstraZeneca and Royal Mail in the spotlight on Thursday
AstraZeneca and Royal Mail are among the notable names in Thursday's diary.
South Africa stops use of AstraZeneca vaccine due to new variant worries
The AstraZeneca vaccine and the alternative developed by Pfizer/BioNTech both work very well against the original form of Covid-19.
UK Government teams up with CureVac to find mutant COVID-19 vaccine
Earlier this week, Curevac announced it had agreed a €150mln joint venture with GlaxoSmithKline to develop mRNA-based vaccines
AstraZeneca says Imfinzi misses target in final stage head and neck cancer trial
Insights from the KESTREL Phase III trial will advance our understanding and application of immunotherapy, the FTSE 100 company said
Coronavirus: UK starts vaccine trials mixing AstraZeneca doses with Pfizer/BioNTech jab
Participants will receive different COVID-19 vaccines for their first or second dose
AstraZeneca gets heart failure treatment approved in China
The therapy can be used in adults with heart failure with problems to the left ventricle and without type-2 diabetes
Coronavirus: Russian vaccine Sputnik V shows 91.6% efficacy rate
The jab was safe and offered complete protection against hospitalisation and death
Coronavirus: UK launches surge testing to detect South African variant, vaccines less effective against it
This weel AstraZeneca is expected to release tests on its vaccine against the new strain, with most competitors reporting lower efficacy rates
Coronavirus: Ryanair says EU needs to speed up vaccine rollout, AstraZeneca to deliver extra 9mln vaccine doses to EU
The row between the pharma giant and the bloc has culminated in a promise for more supplies, while the UK is on track to meet its mid-February vaccination target